Correlations Between Oxidative Stress Biomarkers, h-FABP and Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Undergoing Primary PCI
Ключови думи
Резюме
Описание
Gathered data:
- Descriptive general demographic data;
- Previous pathologies (ischemic heart disease, peripheral arterial disease, stroke, heart failure, previous percutaneous coronary interventions, coronary artery bypass grafting - CABG, known renal disease);
- Cardiovascular risk factors (age, weight, height, abdominal perimeter, body mass index, smoking, sedentariness, diabetes, hypertension, dyslipidaemia);
- Oxidative Stress biomarkers: Catalase Activity Assay; Lipid Peroxidation Assay; SOD Assay; Total Antioxidant Capacity Assay; Glutathione ;
- Cardiac necrosis markers: Heart Fatty Acid Binding Protein (H-FABP), TnI, CK, CK-MB, LDH and OGT;
- Routine biological data;
- Metabolic data (obtained from two body composition monitoring evaluations - before and 12 hours after coronary intervention) - body water, body fat tissue;
- Information regarding primary PCI (less than 12 hours of ischemic symptoms);
- Coronarographic details, type of used stent, periprocedural specific complications, final TIMI - thrombolysis in myocardial infarction - flow);
- Echocardiography at admission (LVEF);
- Measurement of arterial stiffness through Sphigmocore pulsed-wave-velocity (24 hrs post-procedural, 2 velocities: carotid - femoral and carotid - radial);
- Calculating of cardiovascular risk scores: Syntax Score, Framingham score, ASSIGN score, QRISK2 score, PROCAM score, CRUSADE score, GRACE score, CHADS VASc score, MESA score, ASCVD score, Hamilton Depression Rating Scale (HAM-D), Hamilton Rating Scale for Anxiety;
- In-hospital and one month follow-up MACE.
Дати
Последна проверка: | 06/30/2019 |
Първо изпратено: | 07/23/2019 |
Очаквано записване подадено: | 07/23/2019 |
Първо публикувано: | 07/28/2019 |
Изпратена последна актуализация: | 07/26/2019 |
Последна актуализация публикувана: | 07/29/2019 |
Действителна начална дата на проучването: | 07/31/2019 |
Приблизителна дата на първично завършване: | 06/30/2020 |
Очаквана дата на завършване на проучването: | 07/31/2020 |
Състояние или заболяване
Интервенция / лечение
Other: primary PCI STEMI patients
Фаза
Групи за ръце
Arm | Интервенция / лечение |
---|---|
Other: primary PCI STEMI patients All Patients with AMI refered for primary PCI in single center | Other: primary PCI STEMI patients Dosing oxidative stress biomarkers and hFABP in STEMI pPCI |
Критерии за допустимост
Възрасти, отговарящи на условията за проучване | 18 Years Да се 18 Years |
Полове, допустими за проучване | All |
Приема здрави доброволци | Да |
Критерии | Inclusion Criteria: - Adults with ST elevation Myocardial Infarction (<12h) diagnostic confirmed; - Included in the Romanian National Programme of Primary Percutaneous Revascularisation (for who the Guidelines recommend primary PCI); Exclusion Criteria: - Patients who do not sign informed consent for primary PCI |
Резултат
Първични изходни мерки
1. Oxidative Stress status in Acute Myocardial Infarction Patients undergoing primary PCI [1 year]
2. 2. Cardiac necrosis status in Acute Myocardial Infarction Patients undergoing primary PCI. [1 year]
Вторични изходни мерки
1. Hydation Status in Acute Myocardial Infarction Patients undergoing primary PCI. [1 year]